Brief: Clearbridge Health Says Strategic Alliance Agreement With Guangdong Amoreneg Medicine Research And Development Co
06/06/2025 13:05
June 6 (Reuters) - Clearbridge Health Ltd CLEA.SI: ENTERED INTO A STRATEGIC ALLIANCE AGREEMENT WITH GUANGDONG AMORENEG MEDICINE RESEARCH AND DEVELOPMENT CO GAMRD INTENDS TO APPOINT GROUP ENTITY AS FIRST DISTRIBUTOR FOR STEM CELL PRODUCTS WITHIN ASIA (EXCLUDING CHINA) Further company coverage: CLEA.SI ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearbridge Health
See all newsBrief: Clearbridge Health Says Cessation Of Wu Yu Liang As Independent Chairman
Brief: Clearbridge Health Says Cessation Of Wu Yu Liang As Non-Executive And Independent Chairman
Brief: Clearbridge Health's Unit Sells 100% Of Clearbridge Medical Hong Kong
Singapore's Clearbridge Health half-year revenue falls on discontinued Dental Group operations
Brief: Clearbridge Health Appoints Wu Yu Liang As Non-Executive And Independent Chairman